D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)

D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report‪)‬

Clinical Chemistry 2004, July, 50, 7

    • $5.99
    • $5.99

Publisher Description

Deep venous thrombosis (DVT) (4) is a common condition with significant morbidity and mortality if not diagnosed and treated in a timely manner. The clinical signs and symptoms of DVT are nonspecific, and objective testing is required for diagnosis. Diagnostic imaging with contrast venography or compression ultrasonography has important limitations. Venography is invasive and expensive, is contraindicated in some patients, and requires a radiologist to perform. Compression ultrasound also requires a radiologist's interpretation and has poor sensitivity for detection of calf vein thrombosis, and serial testing is often required when the initial scan is negative. The measurement of D-dimer, degradation products of circulating cross-linked fibrin formed during activation of the coagulation system, has been studied extensively as an adjuvant test in the diagnosis of DVT. D-Dimer testing has become rapid, simple, and inexpensive, and it has the potential to detect thrombosis in any part of the venous system. If the sensitivity of the D-dimer test for DVT is consistently very high, its negative predictive value will also be high and reliably exclude the presence of disease. These are characteristics of a good "rule-out" test. As such, the use of D-dimer assays has been suggested as an initial test to rule out DVT to reduce the number of patients requiring diagnostic imaging. In 1996, our systematic review did not find sufficient evidence to support the use of D-dimer as a diagnostic test for DVT (1). However, since that time several new D-dimer assays have been introduced, and 50 studies and 8 reviews on the subject have been published (2-9). Because none of the reviews critically appraised the primary studies or discussed the potential for bias in their results, we undertook this metaanalysis of the D-dimer accuracy literature published since our last systematic review to clarify the role of the test in the diagnosis of lower extremity DVT.

GENRE
Science & Nature
RELEASED
2004
July 1
LANGUAGE
EN
English
LENGTH
40
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
232.8
KB

More Books by Clinical Chemistry

Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report) Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey) Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology) T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998
High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics) High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics)
2008